Roland Sonntag - Concepedia

Author

Roland Sonntag

Also Known As

R SONNTAG, R Sonntag, R W Sonntag, R. Sonntag, R. W. Sonntag, R.W Sonntag, R.W. Sonntag, ROLAND W. SONNTAG, Roland Sonntag, Roland W. Sonntag

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

University Hospital of Bern RWTH Aachen University University of Bern Swiss Group For Clinical Cancer Research Universidad Complutense de Madrid

About

Roland Sonntag is an author at University Hospital of Bern specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	11	1.1K
2	Health Sciences	2	2	397
3	Cell Biology	2	2	166
4	Immunology	2	2	105
5	Hepatology	1	1	84

Roland Sonntag

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
Adjuvant Cisplatin Chemotherapy Following Cystectomy for Bladder Cancer: Results of a Prospective Randomized Trial Urs E. Studer, M. Bacchi, C Biedermann, The Journal of Urology Radical CystectomyUrologySurgical OncologyControl GroupGenitourinary Cancer	1994	252
Enlargement of Regional Lymph Nodes in Renal Cell Carcinoma is Often not Due to Metastases Urs E. Studer, Stephanie Scherz, J. Scheidegger, The Journal of Urology UrologyComputerized TomographyHealth SciencesMedical ImagingGenitourinary Cancer	1990	233
VP-16-213 monotherapy for remission induction of small cell lung cancer: a randomized trial using three dosage schedules. Franco Cavalli, Roland Sonntag, F Jungi, PubMed MedicineCancer ManagementClinical TrialsDosage SchedulesRandomized Trial	1978	164
LONG-TERM RESULTS FOLLOWING ADJUVANT CHEMOTHERAPY IN PATIENTS WITH CLINICAL STAGE I TESTICULAR NONSEMINOMATOUS MALIGNANT GERM CELL TUMORS WITH HIGH RISK FACTORS Roland Sonntag, Urs E. Studer The Journal of Urology	1999	114
Primary or Secondary Extragonadal Germ Cell Tumors? A. Böhle, Urs E. Studer, Roland Sonntag, The Journal of Urology UrologyTumoral PathologyMedicineHistopathologyPretreatment Examination	1986	109
LONG-TERM RESULTS FOLLOWING ADJUVANT CHEMOTHERAPY IN PATIENTS WITH CLINICAL STAGE I TESTICULAR NONSEMINOMATOUS MALIGNANT GERM CELL TUMORS WITH HIGH RISK FACTORS Dominik Böhlen, Markus Borner, Roland Sonntag, The Journal of Urology UrologySurgical OncologyGenitourinary CancerMalignant DiseaseMedicine	1999	106
Cyclin E1 and cyclin-dependent kinase 2 are critical for initiation, but not for progression of hepatocellular carcinoma Roland Sonntag, Nives Giebeler, Yulia A. Nevzorova, Proceedings of the National Academy of Sciences	2018	92
Functional role of CCL5/RANTES for HCC progression during chronic liver disease Antje Mohs, Nadine Kuttkat, Johanna Reißing, Journal of Hepatology HepatologyLiver PhysiologyChronic Liver DiseaseImmunologyFunctional Role	2016	84
microRNA 193a-5p Regulates Levels of Nucleolar- and Spindle-Associated Protein 1 to Suppress Hepatocarcinogenesis Sanchari Roy, Guido Hooiveld, Marco Seehawer, Gastroenterology Developmental BiologySpindle-associated Protein 1Liver PhysiologyRna BiologyMicrorna Detection	2018	82
Pro-apoptotic Sorafenib signaling in murine hepatocytes depends on malignancy and is associated with PUMA expression in vitro and in vivo Roland Sonntag, J-M Bangen, Christian Trautwein, Cell Death and Disease	2014	75

Page 1